Aikaterini S.
- Country
- Greece
- Department
- Child Health Sector
Research Overview
- Safety Evaluation of Long-term Finerenone with ACE Inhibitor or Angiotensin Receptor Blocker in Pediatric Chronic Kidney Disease with Proteinuria
- Evaluation of Finerenone in Combination with ACEI or ARB for Proteinuria and Chronic Kidney Disease in Pediatric Patients: A Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 66 of 66 partner sites.
Specializations
Pediatric Nephrology
The investigator specializes in treating chronic kidney disease in pediatric and young adult populations, with particular emphasis on managing conditions affecting children from ages 1 to 18 years.
- Chronic Kidney Disease Management
- Pediatric Proteinuria Treatment
- Renal Protection Strategies
Their research focuses on innovative therapeutic approaches for kidney disorders in young patients.
Therapeutic Innovation
The investigator explores novel therapeutic combinations, including the use of mineralocorticoid receptor antagonists alongside established treatments such as ACE inhibitors and angiotensin receptor blockers.
- Combination Therapy Approaches
- Long-term Treatment Safety
- Protein Excretion Reduction
Their work encompasses comprehensive evaluation of treatment safety and efficacy in pediatric populations.
Clinical Applications
The investigator's expertise extends to studying therapeutic interventions that address protein excretion disorders in children with chronic kidney conditions.
- Proteinuria Management
- Renal Function Assessment
- Treatment Response Monitoring
Their research evaluates pharmacological responses and clinical outcomes in young patients with kidney disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.